ASH 2022 | The current standard of care for MDS-related cytopenias and how treatment strategies may evolve
Valeria Santini
• 12 Dec 2022
In this video, Valeria Santini, MD, University of Florence, Florence, Italy, shares some insights into the current standard of care (SOC) for myelodysplastic syndrome (MDS)-related cytopenias and highlights potential therapeutic strategies for these. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Novartis, AbbVie, BMS, Gilead, Menarini, Geron, Otsuka: Honoraria.
